Realigning Priorities in the Evaluation and Management of Patients With Heart Failure
- 1 December 2023
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 8 (12) , 1163-1164
Abstract
In this issue of JAMA Cardiology, Perera and coauthors report that myocardial viability status has no influence on the outcomes associated with either percutaneKeywords
This publication has 5 references indexed in Scilit:
- Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular DysfunctionJAMA Cardiology, 2023
- Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still AliveJAMA Cardiology, 2023
- Percutaneous Revascularization for Ischemic Left Ventricular DysfunctionNew England Journal of Medicine, 2022
- Faculty Opinions recommendation of Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy.2016
- Coronary-Artery Bypass Surgery in Patients with Ischemic CardiomyopathyNew England Journal of Medicine, 2016